These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 32693802)

  • 1. Left atrial longitudinal strain as a predictor of Cancer therapeutics-related cardiac dysfunction in patients with breast Cancer.
    Park H; Kim KH; Kim HY; Cho JY; Yoon HJ; Hong YJ; Park HW; Kim JH; Ahn Y; Jeong MH; Cho JG
    Cardiovasc Ultrasound; 2020 Jul; 18(1):28. PubMed ID: 32693802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Early Left Atrial Functional Decline in Predicting Cardiotoxicity in HER2 Positive Breast Cancer Patients Treated With Trastuzumab.
    Bergamini C; Niro L; Springhetti P; Ferri L; Trento L; Minnucci I; Maffeis C; Tafciu E; Rossi A; Fiorio E; Benfari G; Ribichini F
    Cardiovasc Toxicol; 2024 Jun; 24(6):550-562. PubMed ID: 38696070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of cancer therapy-related cardiac dysfunction in breast cancer women using a new speckle tracking echocardiography index: The GAVS.
    Di Lisi D; Madaudo C; Ortello A; Rubino L; Scelfo D; Sinagra FP; Comparato F; Triolo OF; Rossetto L; Galassi AR; Novo G
    Echocardiography; 2024 Aug; 41(8):e15881. PubMed ID: 39007868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of mitral annular velocity as an alternative marker of left ventricular global longitudinal strain to detect the risk of cancer therapy-related cardiac disorders.
    Ichikawa N; Nishizaki Y; Miyazaki S; Nojima M; Kataoka K; Kasahara R; Takei J; Asano T; Komiyama N
    Echocardiography; 2024 Jul; 41(7):e15877. PubMed ID: 38952246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive Measures of Ventricular-Arterial Coupling and Circumferential Strain Predict Cancer Therapeutics-Related Cardiac Dysfunction.
    Narayan HK; French B; Khan AM; Plappert T; Hyman D; Bajulaiye A; Domchek S; DeMichele A; Clark A; Matro J; Bradbury A; Fox K; Carver JR; Ky B
    JACC Cardiovasc Imaging; 2016 Oct; 9(10):1131-1141. PubMed ID: 27085442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Prognostic Value of Left Ventricular Global Longitudinal Strain for Early Prediction of Chemotherapy-Induced Cardiotoxicity: A Systematic Review and Meta-analysis.
    Oikonomou EK; Kokkinidis DG; Kampaktsis PN; Amir EA; Marwick TH; Gupta D; Thavendiranathan P
    JAMA Cardiol; 2019 Oct; 4(10):1007-1018. PubMed ID: 31433450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incremental value of left atrial mechanical dispersion over CHA
    Kupczynska K; Michalski BW; Miskowiec D; Kasprzak JD; Szymczyk E; Wejner Mik P; Lipiec P
    Echocardiography; 2018 May; 35(5):651-660. PubMed ID: 29691894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional speckle-tracking echocardiography for the global and regional assessments of left ventricle myocardial deformation in breast cancer patients treated with anthracyclines.
    Coutinho Cruz M; Moura Branco L; Portugal G; Galrinho A; Timóteo AT; Rio P; Ilhão Moreira R; Mendonça T; Leal A; Gameiro F; Duarte Oliveira S; Luz R; Cruz Ferreira R
    Clin Res Cardiol; 2020 Jun; 109(6):673-684. PubMed ID: 31559482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redefining anthracycline-related subclinical cardiotoxicity: 'Absolute' and 'relative' change in longitudinal strain.
    Terluk A; Stefani L; Boyd A; Vo K; Byth K; Hui R; Richards D; Thomas L
    ESC Heart Fail; 2024 Oct; 11(5):3210-3221. PubMed ID: 38887181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left atrial strain is reduced following trastuzumab in breast cancer patients.
    Lassen MCH; Arya F; Biering-Sørensen T; Reeh JLT; Melisko ME; Sarwary S; Baik AH; Aras MA; Qasim A
    Echocardiography; 2024 Jan; 41(1):e15751. PubMed ID: 38284677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability in echocardiography and MRI for detection of cancer therapy cardiotoxicity.
    Lambert J; Lamacie M; Thampinathan B; Altaha MA; Esmaeilzadeh M; Nolan M; Fresno CU; Somerset E; Amir E; Marwick TH; Wintersperger BJ; Thavendiranathan P
    Heart; 2020 Jun; 106(11):817-823. PubMed ID: 32098808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Combined Echocardiography Approach for the Diagnosis of Cancer Therapy-Related Cardiac Dysfunction in Women With Early-Stage Breast Cancer.
    Esmaeilzadeh M; Urzua Fresno CM; Somerset E; Shalmon T; Amir E; Fan CS; Brezden-Masley C; Thampinathan B; Thevakumaran Y; Yared K; Koch CA; Abdel-Qadir H; Woo A; Yip P; Marwick TH; Chan R; Wintersperger BJ; Thavendiranathan P
    JAMA Cardiol; 2022 Mar; 7(3):330-340. PubMed ID: 35138325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of Integrating Heart Failure Risk Factors Into Impairment of Global Longitudinal Strain to Predict Anthracycline-Related Cardiac Dysfunction.
    Milks MW; Velez MR; Mehta N; Ishola A; Van Houten T; Yildiz VO; Reinbolt R; Lustberg M; Smith SA; Orsinelli DA
    Am J Cardiol; 2018 Apr; 121(7):867-873. PubMed ID: 29454478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left Atrial Reservoir Function and Outcome in Heart Failure With Reduced Ejection Fraction.
    Carluccio E; Biagioli P; Mengoni A; Francesca Cerasa M; Lauciello R; Zuchi C; Bardelli G; Alunni G; Coiro S; Gronda EG; Ambrosio G
    Circ Cardiovasc Imaging; 2018 Nov; 11(11):e007696. PubMed ID: 30571318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arterial Stiffness May Predict Subsequent Cancer Therapy-Related Cardiac Dysfunction in Breast Cancer Patients.
    Şahin M; Kazaz SN; Kartaler F; Kodal B; Altuntaş S; Yüce E; Turan OE; Kutlu M
    Cardiovasc Toxicol; 2024 Apr; 24(4):375-384. PubMed ID: 38457021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in Cardiovascular Biomarkers With Breast Cancer Therapy and Associations With Cardiac Dysfunction.
    Demissei BG; Hubbard RA; Zhang L; Smith AM; Sheline K; McDonald C; Narayan V; Domchek SM; DeMichele A; Shah P; Clark AS; Fox K; Matro J; Bradbury AR; Knollman H; Getz KD; Armenian SH; Januzzi JL; Tang WHW; Liu P; Ky B
    J Am Heart Assoc; 2020 Jan; 9(2):e014708. PubMed ID: 31959034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strain-oriented strategy for guiding cardioprotection initiation of breast cancer patients experiencing cardiac dysfunction.
    Santoro C; Esposito R; Lembo M; Sorrentino R; De Santo I; Luciano F; Casciano O; Giuliano M; De Placido S; Trimarco B; Lancellotti P; Arpino G; Galderisi M
    Eur Heart J Cardiovasc Imaging; 2019 Dec; 20(12):1345-1352. PubMed ID: 31326981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-dimensional speckle tracking echocardiography help identify breast cancer therapeutics-related cardiac dysfunction.
    Liu W; Li W; Li H; Li Z; Zhao P; Guo Z; Liu C; Sun L; Wang Z
    BMC Cardiovasc Disord; 2022 Dec; 22(1):548. PubMed ID: 36522712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between regional left ventricular dysfunction and cancer-therapy-related cardiac dysfunction.
    Saijo Y; Kusunose K; Okushi Y; Yamada H; Toba H; Sata M
    Heart; 2020 Nov; 106(22):1752-1758. PubMed ID: 32209616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Circulating Cardiomyocyte Cell-Free DNA With Cancer Therapy-Related Cardiac Dysfunction in Patients Undergoing Treatment for ERBB2-Positive Breast Cancer.
    Yu AF; Moore ZR; Moskowitz CS; Liu JE; Dang CT; Ramanathan L; Oeffinger KC; Steingart RM; Schmitt AM
    JAMA Cardiol; 2023 Jul; 8(7):697-702. PubMed ID: 37256614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.